Literature DB >> 6321120

DNA sequence analysis of the type-common glycoprotein-D genes of herpes simplex virus types 1 and 2.

L A Lasky, D J Dowbenko.   

Abstract

The DNA sequences for the coding and flanking regions of the type-common glycoprotein-D (gD) genes of herpes simplex virus (HSV) types 1 and 2 have been determined. The resultant protein sequences are approximately 80% homologous. Both gD proteins are 393 amino acids long and both have maintained three identical potential glycosylation sites. Amino acid changes are found throughout the proteins, with the majority of changes located in the amino and carboxyl/termini. Most of the amino acid differences were found to be conservative. Hydropathy analysis, which determines hydrophobic and hydrophilic regions, reveals a remarkable structural similarity between the proteins. Examination of 5' flanking sequences demonstrates extensive DNA sequence homology adjacent to the start of gD gene transcription. In addition, another homologous noncoding region was found 3' to the gD gene. This second homologous sequence is 5' to a 1.6-kb transcription unit.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321120     DOI: 10.1089/dna.1.1984.3.23

Source DB:  PubMed          Journal:  DNA        ISSN: 0198-0238


  30 in total

1.  Detection of Herpes simplex virus DNA by real-time PCR.

Authors:  H H Kessler; G Mühlbauer; B Rinner; E Stelzl; A Berger; H W Dörr; B Santner; E Marth; H Rabenau
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

2.  The domains of glycoprotein D required to block apoptosis depend on whether glycoprotein D is present in the virions carrying herpes simplex virus 1 genome lacking the gene encoding the glycoprotein.

Authors:  G Zhou; B Roizman
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling.

Authors:  Mina Kalantari-Dehaghi; Sookhee Chun; Aziz Alami Chentoufi; Jozelyn Pablo; Li Liang; Gargi Dasgupta; Douglas M Molina; Algis Jasinskas; Rie Nakajima-Sasaki; Jiin Felgner; Gary Hermanson; Lbachir BenMohamed; Philip L Felgner; D Huw Davies
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

4.  Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blotting.

Authors:  G H Cohen; V J Isola; J Kuhns; P W Berman; R J Eisenberg
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

5.  Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2.

Authors:  D S Schmid; D R Brown; R Nisenbaum; R L Burke; D Alexander; R Ashley; P E Pellett; W C Reeves
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

6.  Computer predictions of antigenic domains in herpes simplex virus types 1 and 2 glycoprotein D as compared with experimentally proven domains.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1991-10       Impact factor: 2.332

7.  The carboxy terminus of human immunodeficiency virus type 1 gp160 limits its proteolytic processing and transport in transfected cell lines.

Authors:  O K Haffar; G R Nakamura; P W Berman
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

8.  Localization of epitopes of herpes simplex virus type 1 glycoprotein D.

Authors:  R J Eisenberg; D Long; M Ponce de Leon; J T Matthews; P G Spear; M G Gibson; L A Lasky; P Berman; E Golub; G H Cohen
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

9.  Influence of asparagine-linked oligosaccharides on antigenicity, processing, and cell surface expression of herpes simplex virus type 1 glycoprotein D.

Authors:  D L Sodora; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

10.  Structure-function analysis of soluble forms of herpes simplex virus glycoprotein D.

Authors:  A V Nicola; S H Willis; N N Naidoo; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.